Rules for access to radiation protection areas In accordance with the French decree 2018-437 regarding the protection of workers against the risks of ionising radiation, Users coming for an experiment
Recherche
Recherche de *.
551 résultats ont été trouvés en 1 millisecondes.
Affiche les résultats de 41 à 50 sur 551.
Pages
Pertinence: 100%
Pages
9th July 2018: Grenoble, France – the Institut Laue-Langevin (ILL) and European Synchrotron Radiation Facility (ESRF) team up with leading European space companies OHB System AG and MT Aerospace AG to
Pertinence: 100%
Pages
The Biology, Deuteration, Chemistry and soft matter (BDCS) group (website under construction) In order to maintain their ranking at an international level, European research infrastructures must optim
Pertinence: 100%
Pages
Norman Ramsey at the ILL Reinhard Scherm (ILL director) and Bob Golub ©1993 Katalina Mampe archives by Bob Golub , October 2022 If you look at the first chapter in Norman Ramsey’s book " Spectroscopy
Pertinence: 100%
Pages
Bone strengths Our bones are composed of aggregation of collagen and hydroxyapatite crystals aggregates Ca 10 (PO 4 ) 6 (OH 2 ). They are a living material with some amazing features; if damaged, they
Pertinence: 100%
Pages
(html - 19.92 Ki) Bernard Jacrot's book "Neutrons for Science: the story of the ILL, a very successful international cooperation" English version of Bernard Jacrot's book (html - 19.92 Ki) "Des neutro
Pertinence: 100%
Pages
Secretary E-mail dubouloz(at)ill.eu Room Building ILL 4 - Office 104 Phone +33 (0)4 76 20 7226 Fax +33 (0)4 76 20 7648
Pertinence: 100%
Pages
Brochure générale (2024) (pdf - 19.29 Mi) Livret ILL (2024) (pdf - 4.08 Mi) Ce livret de 16 pages offre un aperçu de l'histoire, de la mission, des capacités de recherche et des activités de l'ILL. Br
Pertinence: 100%
Pages
Opportunités commerciales Pour toute demande relative aux appels d'offres à venir merci de vous rapprocher du Service Achats à l'adresse : tenders@ remove-this. ill.fr Le portail fournisseurs de l'ILL
Pertinence: 100%
Pages
The worst of COVID-19 may have past, but new viral variants keep showing up. Developing new drugs that remain potent against the emerging variants is essential to stopping the spread of the deadly dis
Pertinence: 100%
